NIH Scientists See Therapeutic Potential Against Bacteria, Viruses
National Institutes of Health researchers have identified a naturally occurring lipid—a waxy, fatty acid—used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, they also may have found a potent inflammation therapy against bacterial and viral diseases.
Lipids are known to help Francisella tularensis bacteria, the cause of tularemia, to suppress host inflammation when infecting mouse and human cells. In a new study published in the Journal of Innate Immunity, researchers from NIH’s National Institute of Allergy and Infectious Diseases found a form of the lipid phosphatidylethanoloamine, or PE, present in the bacterium. The composition of PE found in F. tularensis differs from PE found in other bacteria. In cell-culture experiments, the researchers discovered that the natural and a synthetic form of PE reduced inflammation caused by both tularemia bacteria and dengue fever virus.
Tularemia is a life-threatening disease spread to humans via contact with an infected animal or through the bite of a mosquito, tick or deer fly. Although tularemia can be successfully treated with antibiotics, it is difficult to diagnose, mainly because F. tularensis bacteria can suppress the human immune response. Dengue fever, primarily spread by Aedes aegypti mosquitoes, is rarely fatal but usually leads to a high fever, severe headache and pain throughout the body. There is no specific treatment for dengue fever.
After identifying PE as the lipid that impaired the immune response, the scientists began to consider its potential therapeutic value. Because natural F. tularensis is highly infectious and therefore challenging to work with, the group developed synthetic lipids—PE2410 and PEPC2410—that would be much easier to study and produce. They then verified that both synthetic lipids also suppressed the immune response during infection of mouse and human cells in the laboratory.
Because several types of viral infections involve an unconstrained inflammatory response, the group tested natural and their synthetic PE in the laboratory against dengue fever virus-infected human cells. Both versions inhibited the immune response compared to the immune response seen in infected but untreated cells.
The group plans to continue exploring how F. tularensis impairs the immune response. They hope their findings will eventually lead to the development of a potent, broad-spectrum anti-inflammatory therapeutic.
Learn more: Natural Lipid Acts as Potent Anti-Inflammatory
Receive an email update when we add a new INFLAMMATION article.
The Latest on: Inflammation therapy
via Google News
The Latest on: Inflammation therapy
- Smile! This Electric Toothbrush Whitens Teeth Using Light Therapy on November 13, 2018 at 1:33 pm
Shoppers who bought and used the light therapy tooth brush raved most about how effective it is. They noticed whiter teeth, reduced gum bleeding and decreased mouth inflammation. One reviewer shared o... […]
- Exploring the Science, and the Snake Oil, Behind Regenerative Stem Cell Therapy on November 7, 2018 at 7:07 am
This particular seminar was advertised for patients suffering from chronic obstructive pulmonary disease, or COPD, an inflammatory lung condition ... "Experience healing with regenerative stem cell th... […]
- Inflammation-related Protein Complex a Potential Therapy Target for Parkinson’s, Study Says on November 6, 2018 at 4:00 am
Oral administration of a small molecule specifically blocked the activation of a stress-sensing protein complex called the NLRP3 inflammasome and prevented the loss of brain cells, resulting in signif... […]
- Statins May Decrease C-Reactive Protein Levels in Psoriatic Arthritis on October 24, 2018 at 1:15 pm
CHICAGO — Statin therapy may lower C-reactive protein (CRP) levels in patients with psoriatic arthritis (PsA), according to a study presented at the American College of Rheumatology Annual Meeting, Oc... […]
- FDA snubs Novartis bid to repurpose inflammation drug for heart attacks on October 18, 2018 at 10:46 am
The company received an FDA letter turning down its bid to make canakinumab a targeted therapy for those cardiovascular patients who in tests had quickly responded to treatment, as levels of a protein ... […]
- Mid Atlantic Chiropractic Center Adds Low-Level Laser Therapy to Reduce Inflammation and Treat Chronic Pain on September 30, 2018 at 5:00 pm
Frederick, MD -- (ReleaseWire) -- 10/01/2018 -- Individuals seeking effective, non-invasive treatment of inflammation and chronic pain are ideal candidates for low-level laser therapy, now being offer... […]
- The Healing Light - Cold Laser Therapy Comes to Amazing Spine Care in Jacksonville, FL on September 23, 2018 at 4:02 am
Inflammation, swelling, and pain disappear, and the patient feels better quickly as their body rejuvenates. The Cold Laser Therapy procedure only takes a few minutes, and there is no lengthy downtime ... […]
- Red Light LED Therapy At Home Kit Reduced Inflammation Solutions Report Launched on September 11, 2018 at 5:00 pm
Bio Hacker Nation launched a new report on RedRush 360, an at-home red light therapy kit designed to reduce inflammation, promote tissue healing and alleviate pain. Bio Hacker Nation, an informative w... […]
- New England Journal of Medicine publishes two trials for Symbicort as an anti-inflammatory reliever therapy ‘as needed’ in mild asthma on May 17, 2018 at 7:25 am
3,4 The SYGMA trials were designed to evaluate the efficacy of Symbicort Turbuhaler, taken only as needed, as an anti-inflammatory reliever versus current standard of care therapies in mild asthma: In ... […]
via Bing News